Literature DB >> 11690700

Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by interleukin-6.

A Lelbach1, J G Scharf, G Ramadori.   

Abstract

BACKGROUND/AIMS: Catabolism is associated with decreased serum concentrations of insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-3 associated with elevated IGFBP-3 protease activity and increased concentrations of IGFBP-1 and -4. The effects of the acute phase mediators interleukin (IL)-6, IL-1beta and tumor necrosis factor alpha (TNFalpha) on the biosynthesis of IGF-I and IGFBPs were studied in primary rat liver cells.
METHODS: mRNA levels of IGF-I and of IGFBPs were analyzed by Northern blotting, secretion of IGFBPs by [(125)I]IGF-I ligand blotting. Proteolytic activity was measured using iodinated recombinant IGFBP-3 as the substrate.
RESULTS: In hepatocytes, Kupffer cells (KC) and cocultures of hepatocytes with KC, IL-6 reduced IGF-I biosynthesis dose-dependently. IL-6 stimulated mRNA expression and protein secretion of IGFBP-1 and -4 in hepatocytes and that of IGFBP-3 in KC, respectively. In cocultures, biosynthesis of IGFBP-1, -3 and -4 was increased dose-dependently by IL-6, while the effects of IL-1beta or TNFalpha were less prominent. At neutral pH, proteolytic activity against IGFBP-3 was not detected in media of cocultures treated with IL-6.
CONCLUSIONS: The alterations of IGF-I, IGFBP-1 and -4 observed in catabolism correlate with the effects of IL-6 on the biosynthesis of these components in primary rat liver cells, while a neutral IGFBP-3 protease was not detectable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11690700     DOI: 10.1016/s0168-8278(01)00170-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Identification of genes specific to "oval cells" in the rat 2-acetylaminofluorene/partial hepatectomy model.

Authors:  Danko S Batusic; Velasco Cimica; Yonglong Chen; Kyrylo Tron; Thomas Hollemann; Tomas Pieler; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2005-10-28       Impact factor: 4.304

2.  Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes.

Authors:  Mona M Mohamed; Dora Cavallo-Medved; Deborah Rudy; Arulselvi Anbalagan; Kamiar Moin; Bonnie F Sloane
Journal:  Cell Physiol Biochem       Date:  2010-01-12

3.  Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Authors:  Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Hamasaki; Ryuji Furukawa; Shotarou Tsuruta; Yasuo Ueda; Naota Taura; Hidetaka Shibata; Masumi Fujimoto; Kan Toriyama; Katsumi Eguchi
Journal:  Hepatol Int       Date:  2007-06-01       Impact factor: 6.047

4.  The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.

Authors:  L Tay; W S Lim; M Chan; R J Ye; M S Chong
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

5.  Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease.

Authors:  Meena Thayu; Lee A Denson; Justine Shults; Babette S Zemel; Jon M Burnham; Robert N Baldassano; Krista M Howard; Anne Ryan; Mary B Leonard
Journal:  Gastroenterology       Date:  2010-04-22       Impact factor: 22.682

6.  Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

Authors:  P Sarzi-Puttini; F Atzeni; J Schölmerich; M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 7.  Role of insulin-like growth factor I signaling in neurodegenerative diseases.

Authors:  José Luis Trejo; Eva Carro; Eva Garcia-Galloway; Ignacio Torres-Aleman
Journal:  J Mol Med (Berl)       Date:  2003-11-28       Impact factor: 4.599

Review 8.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

9.  Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review.

Authors:  W Kyle Mitchell; John Williams; Philip Atherton; Mike Larvin; John Lund; Marco Narici
Journal:  Front Physiol       Date:  2012-07-11       Impact factor: 4.566

10.  αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway.

Authors:  Ana Isabel Martín; Ana Belén Gómez-SanMiguel; Carolina Gómez-Moreira; María Ángeles Villanúa; Asunción López-Calderón
Journal:  Mediators Inflamm       Date:  2014-09-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.